Juan Manuel Zapata Hernández

Title: Juan Manuel Zapata Hernández: Innovator in Antibody Drug Conjugates

Introduction

Juan Manuel Zapata Hernández is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody drug conjugates. With a total of 2 patents to his name, his work is paving the way for innovative cancer treatments.

Latest Patents

His latest patents focus on antibody drug conjugates, specifically drug conjugates of the formulas [D-(X)-(AA)-(L)-]-Ab and [D-(X)b-(AA)w-(L)-]n-Ab. These conjugates are designed to target cancer cells effectively. The drug moiety D is characterized by a specific formula, and the conjugates include various components such as amino acid units and linker groups. These innovations are crucial for advancing cancer therapies.

Career Highlights

Throughout his career, Juan Manuel has worked with notable companies in the pharmaceutical industry, including Pharma Mar, S.A. His expertise in drug development has positioned him as a key player in the field of oncology.

Collaborations

Juan Manuel has collaborated with esteemed colleagues such as Andrés Francesch Solloso and María Garranzo García-Ibarrola. These partnerships have further enhanced his research and development efforts in biopharmaceuticals.

Conclusion

Juan Manuel Zapata Hernández is a distinguished inventor whose work in antibody drug conjugates is making a significant impact in cancer treatment. His innovative approaches and collaborations continue to drive advancements in the pharmaceutical industry.